18F-FDG PET imaging of atherosclerotic carotid stenosis
Appears in the following Collection
AbstractStroke leads to severe disability and death worldwide. An atherosclerotic plaque causing stenosis of the carotid artery is an important cause of ischemic stroke. Today’s treatment selection is mainly based on the degree of stenosis caused by the plaque. Increasing knowledge indicates that luminal stenosis alone may not be the best predictor of stroke risk. Inflammation is one of the key processes causing atherosclerotic plaque progression, plaque rupture and increased risk of the development of an embolus causing a clinical ischemic cerebral event. Positron emission tomography (PET) with radiolabelled glucose (18F-FDG) can detect and quantify glucose hypermetabolism in inflammatory cells. The aims of this thesis were to determine if 18F-FDG PET can be established as a reliable imaging modality for the detection of atherosclerotic plaques which have a high risk of causing thromboembolic events. Furthermore, to explore if any quantification methods were more suitable than others for implementing 18F-FDG PET assessments of atherosclerosis in multicenter studies and in clinical routine. The study population consisted of symptomatic (minor stroke or transient ischemic attack within the past 30 days) and asymptomatic patients referred to surgical treatment for severe atherosclerotic carotid stenosis (≥70 %). Symptomatic patients had higher carotid plaque uptake of 18F-FDG than asymptomatic. The uptake of 18F-FDG correlated significantly with inflammation on histological assessment. Analysis of different quantification methods showed that all had a good correlation to inflammation on histology. Correction for background activity was not necessary and slightly lowered the inter-reader agreement. The thesis confirms that 18F-FDG PET/CT can detect inflammation and clinical vulnerability in large carotid atherosclerotic plaques. Easy achievable and reproducible quantification measurements are feasible and necessary for the methods use in clinical practice.
List of papers
|I. Karolina Skagen, Kjersti Johnsrud, Kristin Evensen, Helge Scott, Kirsten Krohg-Sørensen, Frode Reier-Nilsen, Mona-Elisabeth Revheim, Jan Gunnar Fjeld, Mona Skjelland, and David Russell. Carotid plaque inflammation assessed with 18F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients. International Journal of Stroke. 2015;10:730-6. The paper is included in the thesis in DUO, and also available at: https://doi.org/10.1111/ijs.12430|
|II. Kjersti Johnsrud, Karolina Skagen, Therese Seierstad, Mona Skjelland, David Russell, and Mona-Elisabeth Revheim. 18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques. Journal of Nuclear Cardiology. 2019;26(3):883-93. The paper is included in the thesis in DUO, and also available at: https://doi.org/10.1007/s12350-017-1121-7|
|III. Kjersti Johnsrud, Therese Seierstad, David Russell, and Mona-Elisabeth Revheim. Inter-reader agreement of 18F-FDG PET/CT for the quantification of carotid artery plaque inflammation. JRSM Cardiovascular Disease. 2020;9:204800402098094. An author version is included in the thesis. The published version is available at: https://doi.org/10.1177/2048004020980941|